ValueRx

SmithKline Beecham 's announcement that it was selling off its non-core businesses in clinical labs and pharmacy benefit management comes as no surprise and represents simply the latest in the disma

Some PBM executives are asking whether Express Scripts Inc. 's $445 million acquisition of ValueRx is the beginning of a long-anticipated consolidation of the PBM industry, a consolidation that